Evaluation of the accelerate pheno system

Results from two academic medical centers

Joseph D. Lutgring, Cassiana Bittencourt, Erin Mc Elvania TeKippe, Dominick Cavuoti, Rita Hollaway, Eileen M. Burd

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Rapid diagnostic tests are needed to improve patient care and to combat the problem of antimicrobial resistance. The Accelerate Pheno system (Accelerate Diagnostics, Tucson, AZ) is a new diagnostic device that can provide rapid bacterial identification and antimicrobial susceptibility test (AST) results directly from a positive blood culture. The device was compared to the standard of care at two academic medical centers. There were 298 blood cultures included in the study, and the Accelerate Pheno system provided a definitive identification result in 218 instances (73.2%). The Accelerate Pheno system provided a definitive and correct result for 173 runs (58.1%). The Accelerate Pheno system demonstrated an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 94.7%, 98.9%, 83.7%, and 99.7%, respectively. An AST result was available for analysis in 146 instances. The overall category agreement was 94.1% with 12 very major errors, 5 major errors, and 55 minor errors. After a discrepancy analysis, there were 5 very major errors and 4 major errors. The Accelerate Pheno system provided an identification result in 1.4 h and an AST result in 6.6 h; the identification and AST results were 41.5 h and 48.4 h faster than those with the standard of care, respectively. This study demonstrated that the Accelerate Pheno system is able to provide fast and accurate organism identification and AST data. A limitation is the frequency with which cultures required the use of alternative identification and AST methods.

Original languageEnglish (US)
Article numbere01672
JournalJournal of Clinical Microbiology
Volume56
Issue number4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Standard of Care
Equipment and Supplies
Routine Diagnostic Tests
Patient Care
Sensitivity and Specificity
Blood Culture

Keywords

  • antimicrobial resistance
  • Antimicrobial susceptibility testing
  • Bacteremia
  • Bloodstream infections
  • Diagnostics
  • Rapid diagnostic testing

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Evaluation of the accelerate pheno system : Results from two academic medical centers. / Lutgring, Joseph D.; Bittencourt, Cassiana; TeKippe, Erin Mc Elvania; Cavuoti, Dominick; Hollaway, Rita; Burd, Eileen M.

In: Journal of Clinical Microbiology, Vol. 56, No. 4, e01672, 01.04.2018.

Research output: Contribution to journalArticle

Lutgring, Joseph D. ; Bittencourt, Cassiana ; TeKippe, Erin Mc Elvania ; Cavuoti, Dominick ; Hollaway, Rita ; Burd, Eileen M. / Evaluation of the accelerate pheno system : Results from two academic medical centers. In: Journal of Clinical Microbiology. 2018 ; Vol. 56, No. 4.
@article{4f54b3413a9e44b3b2b9b80f00ec0be5,
title = "Evaluation of the accelerate pheno system: Results from two academic medical centers",
abstract = "Rapid diagnostic tests are needed to improve patient care and to combat the problem of antimicrobial resistance. The Accelerate Pheno system (Accelerate Diagnostics, Tucson, AZ) is a new diagnostic device that can provide rapid bacterial identification and antimicrobial susceptibility test (AST) results directly from a positive blood culture. The device was compared to the standard of care at two academic medical centers. There were 298 blood cultures included in the study, and the Accelerate Pheno system provided a definitive identification result in 218 instances (73.2{\%}). The Accelerate Pheno system provided a definitive and correct result for 173 runs (58.1{\%}). The Accelerate Pheno system demonstrated an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 94.7{\%}, 98.9{\%}, 83.7{\%}, and 99.7{\%}, respectively. An AST result was available for analysis in 146 instances. The overall category agreement was 94.1{\%} with 12 very major errors, 5 major errors, and 55 minor errors. After a discrepancy analysis, there were 5 very major errors and 4 major errors. The Accelerate Pheno system provided an identification result in 1.4 h and an AST result in 6.6 h; the identification and AST results were 41.5 h and 48.4 h faster than those with the standard of care, respectively. This study demonstrated that the Accelerate Pheno system is able to provide fast and accurate organism identification and AST data. A limitation is the frequency with which cultures required the use of alternative identification and AST methods.",
keywords = "antimicrobial resistance, Antimicrobial susceptibility testing, Bacteremia, Bloodstream infections, Diagnostics, Rapid diagnostic testing",
author = "Lutgring, {Joseph D.} and Cassiana Bittencourt and TeKippe, {Erin Mc Elvania} and Dominick Cavuoti and Rita Hollaway and Burd, {Eileen M.}",
year = "2018",
month = "4",
day = "1",
doi = "10.1128/JCM.01672-17",
language = "English (US)",
volume = "56",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "4",

}

TY - JOUR

T1 - Evaluation of the accelerate pheno system

T2 - Results from two academic medical centers

AU - Lutgring, Joseph D.

AU - Bittencourt, Cassiana

AU - TeKippe, Erin Mc Elvania

AU - Cavuoti, Dominick

AU - Hollaway, Rita

AU - Burd, Eileen M.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Rapid diagnostic tests are needed to improve patient care and to combat the problem of antimicrobial resistance. The Accelerate Pheno system (Accelerate Diagnostics, Tucson, AZ) is a new diagnostic device that can provide rapid bacterial identification and antimicrobial susceptibility test (AST) results directly from a positive blood culture. The device was compared to the standard of care at two academic medical centers. There were 298 blood cultures included in the study, and the Accelerate Pheno system provided a definitive identification result in 218 instances (73.2%). The Accelerate Pheno system provided a definitive and correct result for 173 runs (58.1%). The Accelerate Pheno system demonstrated an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 94.7%, 98.9%, 83.7%, and 99.7%, respectively. An AST result was available for analysis in 146 instances. The overall category agreement was 94.1% with 12 very major errors, 5 major errors, and 55 minor errors. After a discrepancy analysis, there were 5 very major errors and 4 major errors. The Accelerate Pheno system provided an identification result in 1.4 h and an AST result in 6.6 h; the identification and AST results were 41.5 h and 48.4 h faster than those with the standard of care, respectively. This study demonstrated that the Accelerate Pheno system is able to provide fast and accurate organism identification and AST data. A limitation is the frequency with which cultures required the use of alternative identification and AST methods.

AB - Rapid diagnostic tests are needed to improve patient care and to combat the problem of antimicrobial resistance. The Accelerate Pheno system (Accelerate Diagnostics, Tucson, AZ) is a new diagnostic device that can provide rapid bacterial identification and antimicrobial susceptibility test (AST) results directly from a positive blood culture. The device was compared to the standard of care at two academic medical centers. There were 298 blood cultures included in the study, and the Accelerate Pheno system provided a definitive identification result in 218 instances (73.2%). The Accelerate Pheno system provided a definitive and correct result for 173 runs (58.1%). The Accelerate Pheno system demonstrated an overall sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 94.7%, 98.9%, 83.7%, and 99.7%, respectively. An AST result was available for analysis in 146 instances. The overall category agreement was 94.1% with 12 very major errors, 5 major errors, and 55 minor errors. After a discrepancy analysis, there were 5 very major errors and 4 major errors. The Accelerate Pheno system provided an identification result in 1.4 h and an AST result in 6.6 h; the identification and AST results were 41.5 h and 48.4 h faster than those with the standard of care, respectively. This study demonstrated that the Accelerate Pheno system is able to provide fast and accurate organism identification and AST data. A limitation is the frequency with which cultures required the use of alternative identification and AST methods.

KW - antimicrobial resistance

KW - Antimicrobial susceptibility testing

KW - Bacteremia

KW - Bloodstream infections

KW - Diagnostics

KW - Rapid diagnostic testing

UR - http://www.scopus.com/inward/record.url?scp=85044711052&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044711052&partnerID=8YFLogxK

U2 - 10.1128/JCM.01672-17

DO - 10.1128/JCM.01672-17

M3 - Article

VL - 56

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 4

M1 - e01672

ER -